US vaccine maker Moderna has announced that it will build its first mRNA jab-manufacturing facility in Africa after signing an agreement with Kenya's government to produce up to 500 million doses a year, reports AFP.

The company said it expected to invest $500 million in the new facility, which will produce vaccines for the continent of 1.3 billion people whose population has been largely shut out of access to Covid-19 jabs.

Moderna said it hopes to use the facility to supply doses of its Covid-19 jab to African nations as early as next year, in a bid to boost vaccine coverage on the world's least immunised continent.

Opinion

Editorial

Sustainable path?
Updated 13 Jun, 2026

Sustainable path?

The FY27 budget is the first clear signal that the government is ready to transition from stabilisation to growth.
Prioritising education
13 Jun, 2026

Prioritising education

THOUGH the improvement in the country’s literacy rate may be slight, as highlighted by the Economic Survey, it ...
Poverty’s rise
13 Jun, 2026

Poverty’s rise

AS attention turns to the government’s plans for the coming fiscal year, one set of figures deserves particular...
A difficult story
Updated 12 Jun, 2026

A difficult story

Unless productivity becomes the dominant target of economic policy, Pakistan will continue to oscillate between crises and fragile recovery.
Rough waters
12 Jun, 2026

Rough waters

AMONGST the key potential triggers for fresh conflict in South Asia is water. The Indian state is behaving in an...
Politicised football
12 Jun, 2026

Politicised football

ALMOST three-and-half years since Lionel Messi led Argentina to FIFA World Cup glory, the latest edition of...